Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Full text

Abstract

Free full text

Publication Types

Journal Article

Review

Randomized Controlled Trial

Clinical Trial

Comparative Study

Letter

Research Support, Non-U.S. Gov't

Observational Study

Publication Year

From

Quick links

Individual year

2021

2019

2017

2012

2004

2003

2000

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Abortifacient Agents, Nonsteroidal""[mesh_terms]

7 Results

Searching titles within these results

Overview and guidelines of off-label use of methotrexate in ectopic pregnancy: report by CNGOF.

Camille Mimoun, Claire Tourette, Sandra Curinier, Benoit Rabishong, Aubert Agostini, Hervé Fernandez, Magali Lesavre, Henri Marret, Arnaud Fauconnier, Gil Dubernard, Hélène Misme, Laurence Lagarce

European journal of obstetrics, gynecology, and reproductive biology 2017;205():105-9

Full Text

Abstract

Comparison between potassium chloride and lidocaine as lethal agents for feticide in termination of pregnancy.

C Dumont, R Rayssiguier, Y Musizzano, M-J Perez, E Mousty, A Ménard, P Boulot, F Fuchs

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology 2019;53(4):546-547

Free Full Text

Methotrexate/misoprostol embryopathy: report of four cases resulting from failed medical abortion.

Margaret P Adam, Melanie A Manning, Anita E Beck, Andrea Kwan, Gregory M Enns, Carol Clericuzio, H Eugene Hoyme

American journal of medical genetics. Part A 2004;123A(1):72-8

Full Text

Abstract

Medical management of ectopic pregnancy.

Gary H Lipscomb

Clinical obstetrics and gynecology 2012;55(2):424-32

Full Text

Abstract

A pharmacologically-based approach to high dose methotrexate administration to investigate nephrotoxicity and acute kidney injury biomarkers in children and adolescents with newly diagnosed osteosarcoma.

Elizabeth Fox, Christine Busch, Alexander DeBernardo, Blair Segers, Joseph Gottschalk, Richard Womer, Naomi Balamuth, Rochelle Bagatell, Frank Balis

Cancer chemotherapy and pharmacology 2021;87(6):807-815

Full Text

Abstract

Vaginal misoprostol alone for medical abortion up to 9 weeks of gestation: efficacy and acceptability.

S W Ngai, O S Tang, P C Ho, Y M Chan

Human reproduction (Oxford, England) 2000;15(5):1159-62

Full Text

Abstract

A study of co-treatment of nonsteroidal anti-inflammatory drugs (NSAIDs) with misoprostol for cervical priming before suction termination of first trimester pregnancy.

Chiu Fai Ivy Li, Chin Yin Grace Wong, Chong Pun Ben Chan, Pak Chung Ho

Contraception 2003;67(2):101-5

Full Text

Abstract

Results: 1 – 7 / 7

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Abortifacient Agents, Nonsteroidal""[mesh_terms]

Overview and guidelines of off-label use of methotrexate in ectopic pregnancy: report by CNGOF.

Comparison between potassium chloride and lidocaine as lethal agents for feticide in termination of pregnancy.

Methotrexate/misoprostol embryopathy: report of four cases resulting from failed medical abortion.

Medical management of ectopic pregnancy.

A pharmacologically-based approach to high dose methotrexate administration to investigate nephrotoxicity and acute kidney injury biomarkers in children and adolescents with newly diagnosed osteosarcoma.

Vaginal misoprostol alone for medical abortion up to 9 weeks of gestation: efficacy and acceptability.

A study of co-treatment of nonsteroidal anti-inflammatory drugs (NSAIDs) with misoprostol for cervical priming before suction termination of first trimester pregnancy.

Results for
""Abortifacient Agents, Nonsteroidal""[mesh_terms]